Search PDMR transactions

Notifier
Name of person with notification obligation
Holger Lembrér
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Holger Lembrér
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Oncopeptides AB
Issuer´s LEI code
549300O897ZC5H7CY412
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Oncopeptides AB SE0009414576 Acquisition 2,262 Quantity 7.792 SEK 08/09/2023 NASDAQ STOCKHOLM AB
Share Oncopeptides AB SE0009414576 Acquisition 654 Quantity 7.79 SEK 08/09/2023 NASDAQ STOCKHOLM AB
Share Oncopeptides AB SE0009414576 Acquisition 66 Quantity 7.748 SEK 08/09/2023 NASDAQ STOCKHOLM AB
Share Oncopeptides AB SE0009414576 Acquisition 1,009 Quantity 7.738 SEK 08/09/2023 NASDAQ STOCKHOLM AB
Share Oncopeptides AB SE0009414576 Acquisition 1,009 Quantity 7.726 SEK 08/09/2023 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Oncopeptides AB SE0009414576 Acquisition 08/09/2023 NASDAQ STOCKHOLM AB 5,000 (Quantity) 7.7669416 SEK
Total: 5,000
<< Back